QA: Skye Bioscience Inc. in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001516551_2020_Skye_Bioscience_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0001516551')"}

Graph

Absolute values for 0001516551, Skye Bioscience Inc.

  xvar xval
0 AssetsCurrent 1,994,760
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 1,983
3 remainder_Assets 0
4 LiabilitiesCurrent 970,818
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 477,867
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 4,394,622
9 ResearchAndDevelopmentExpense 2,237,956
10 remainder_Expenses 1,600
11 remainder_Revenues 0
12 remainder_NetIncome 7,686,003
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 1,996,743
1 Liabilities 1,448,685
2 Expenses 6,634,178
3 Revenues 0
4 StockholdersEquity 548,058
5 NetIncome 1,051,825
6 ComprehensiveNetIncome 1,051,825
7 BaseVar 8,882,804
8 EconomicCapitalRatio 1.16

Edgar->Model Mapping

Feature Distribution

Change over Time